Article
Treatment with 188Re Reduces Cancerous Phenotype in Liver Cancer Cells
2021-04-22
Abstract excerpt
<title>Abstract</title> <p>Background Recurrence in hepatocellular carcinoma (HCC) after conventional treatments is a big challenge. Despite the promising progress in advanced targeted therapies, HCC is the fourth leading cause of cancer death worldwide. Radionuclide therapy could be an effective targeted approach to address this concern. Rhenium-188 (<sup>188</sup>Re) is a β-emitting radionuclide that can be us...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5a16958a-e13f-5ec2-9306-54db7d571b46
- DOI
- 10.21203/rs.3.rs-398524/v1
